All companies
Boston Scientific logo
HealthcareBSX

Boston Scientific (BSX) Financial Forecast Calculator

Interactive 5-year forecast and DCF for Boston Scientific. Adjust revenue growth, gross margin, capex intensity, WACC, and terminal growth - see revenue, free cash flow, and enterprise value update in real time. Seeded from Boston Scientific’s most recent SEC filings.

Revenue FY30
$20.27B
from $14.24B
FCF FY30
$5.78B
Margin 28.5%
Enterprise value
$82.51B
5.8× LTM revenue
Equity value
$72.63B
Net debt $9.88B
Revenue & free cash flow - history and 5-year forecast
Line (area)
Bars
Historicals from SEC EDGAR (grey). Forecast years (color) update live as you move the sliders.

Assumptions

Revenue growth (annual)
7.3%
-10.0%baseline 7.3%40.0%
Gross margin
68.6%
5.0%baseline 68.6%90.0%
Capex % of revenue
4.5%
0.0%baseline 4.5%30.0%
WACC (discount rate)
9.00%
4.0%baseline 9.0%18.0%
Terminal growth
2.50%
0.0%baseline 2.5%5.0%

Need this as an Excel model?

Keep iterating on the Boston Scientific forecast in Excel. The downloadable sample has every assumption you see here plus a fully integrated income statement, balance sheet, cash flow, and debt schedule - five years of SEC historicals and live formulas in a fully editable workbook.

income_statement.xlsx
Income statement, brown brand palette
income_statement.xlsx
Income statement, green brand palette
income_statement.xlsx
Income statement, red brand palette

Frequently asked

What kind of company is Boston Scientific and what medical devices do they produce?+

Boston Scientific is a global developer, manufacturer, and marketer of medical devices used in a broad range of interventional medical specialties. The company operates a high-innovation, direct-sales business model, relying heavily on continuous research and development alongside strategic acquisitions.

What are the primary drivers of Boston Scientific's revenue growth?+

Boston Scientific's revenue growth is primarily driven by the rapid adoption of high-growth product launches, such as the Farapulse Pulsed Field Ablation System and WATCHMAN. Recent strategic acquisitions also play a significant role in impacting long-term revenue expansion.

What is the assumed long-term revenue growth rate in the Boston Scientific financial model?+

The financial model for Boston Scientific assumes a long-term revenue growth rate of approximately 7.3%. This forecast considers the impact of new product introductions and strategic acquisitions on the company's top line.

How does Boston Scientific's aggressive acquisition strategy impact its balance sheet and valuation model inputs?+

Boston Scientific's aggressive acquisition strategy leads to Goodwill and Intangible Assets dominating its balance sheet, representing over 50% of total assets. This significant proportion of intangible assets is a crucial input for equity valuation and scenario planning tools.

Can I download an Excel financial model for Boston Scientific (BSX)?+

Yes, a comprehensive Excel financial model for Boston Scientific (BSX) is available for download. This model serves as an equity valuation and scenario planning tool, allowing users to assess various financial impacts.

What is Boston Scientific's capital expenditure strategy?+

Boston Scientific typically allocates 4.0% to 5.0% of its revenue to capital expenditures. Roughly 60% of this capex is directed towards growth initiatives, primarily expanding manufacturing capacity for new product lines.

Have more financial modelling questions? Contact us

Go further

Build the financial model you need with Fina

Browse templates, examples, and downloadable Excel models for the analysis you are trying to build. If you can't find your model, ask Fina to build a model for your specific needs.

Start for free
Excel financial model spreadsheet preview showing Customer Rollforward
Fina interactive chat interface preview